Bempedoic Acid is an ATP-citrate lyase inhibitor that lowers LDL cholesterol upstream of the HMG-CoA reductase pathway, used as an adjunct to statins or ezetimibe for patients requiring additional lipid-lowering. Simson Pharma's Bempedoic Acid reference standard and impurities support stability-indicating method development for this newer lipid therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bempedoic Acid Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.